SCHEMBL6957239

SCHEMBL6957239

CS(=O)(=O)c1nc(OCC(F)(F)F)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.40
KDM4E B2RXH2 5/20 0.38
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 4/20 0.38
HPGD P15428 3/20 0.38
HTT P42858 3/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
TRPV1 Q8NER1 3/20 0.35
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KHK P50053 2/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4417486 0.85 GRM2 (0.43) PIK3CDGRM2
SCHEMBL6956303 0.84 KDM4E (0.41) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL6957307 0.83 LMNA (0.44) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL6950069 0.82 KDM4E (0.42) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL6947632 0.82 PIK3CD (0.39) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL6955400 0.81 PIK3CD (0.38) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL6948239 0.81 PIK3CD (0.39) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL4417441 0.80 GRM2 (0.41) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL6949294 0.80 KDM4E (0.43) PIK3CDKDM4EKMT2AALDH1A1MEN1
SCHEMBL6954057 0.79 ALDH1A1 (0.39) PIK3CDKDM4EKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed